Serum Albumin Concentrations Are Associated with Disease Severity and Outcomes in Coronavirus 19 Disease (COVID-19): a Systematic Review and Meta-analysis

Overview

Journal Clin Exp Med

Specialty General Medicine

Date 2021 Jan 29

PMID 33511503

Citations 32

Authors

Panagiotis Paliogiannis

Arduino Aleksander Mangoni

Michela Cangemi

Alessandro Giuseppe Fois

Ciriaco Carru

Angelo Zinellu

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for the most threatening pandemic in modern history. The aim of this systematic review and meta-analysis was to investigate the associations between serum albumin concentrations and COVID-19 disease severity and adverse outcomes. A systematic literature search was conducted in PubMed, from inception to October 30, 2020. Sixty-seven studies in 19,760 COVID-19 patients (6141 with severe disease or poor outcome) were selected for analysis. Pooled results showed that serum albumin concentrations were significantly lower in patients with severe disease or poor outcome (standard mean difference, SMD: - 0.99 g/L; 95% CI, - 1.11 to - 0.88, p < 0.001). In multivariate meta-regression analysis, age (t = - 2.13, p = 0.043), publication geographic area (t = 2.16, p = 0.040), white blood cell count (t = - 2.77, p = 0.008) and C-reactive protein (t = - 2.43, p = 0.019) were significant contributors of between-study variance. Therefore, lower serum albumin concentrations are significantly associated with disease severity and adverse outcomes in COVID-19 patients. The assessment of serum albumin concentrations might assist with early risk stratification and selection of appropriate care pathways in this group.

Citing Articles

Stable Nitroxide as Diagnostic Tools for Monitoring of Oxidative Stress and Hypoalbuminemia in the Context of COVID-19.

Georgieva E, Ananiev J, Yovchev Y, Arabadzhiev G, Abrashev H, Zaharieva V Int J Mol Sci. 2024; 25(15).

PMID: 39125614 PMC: 11312055. DOI: 10.3390/ijms25158045.

PBPK-led assessment of antimalarial drugs as candidates for Covid-19: Simulating concentrations at the site of action to inform repurposing strategies.

Abla N, Almond L, Bonner J, Richardson N, Wells T, Mohrle J Clin Transl Sci. 2024; 17(7):e13865.

PMID: 39020517 PMC: 11254780. DOI: 10.1111/cts.13865.

The predictive value of cardiovascular outcomes and mortality assessed by the C-reactive protein to albumin ratio in the UK Biobank.

Wandell P, Carlsson A, Larsson A, Arnlov J, Ruge T, Rydell A BMC Cardiovasc Disord. 2024; 24(1):326.

PMID: 38926672 PMC: 11202353. DOI: 10.1186/s12872-024-03995-9.

Significance of Hypoalbuminemia in the Development of Thromboembolic Complications in Severe Cases of SARS-CoV-2 Coronavirus Infection.

Tarzimanova A, Bragina A, Pokrovskaya A, Ivannikov A, Sokolova E, Cherkesov I J Clin Med Res. 2024; 16(4):164-169.

PMID: 38715557 PMC: 11073384. DOI: 10.14740/jocmr5119.

Current Trends in Biohumoral Screening for the Risk of Sudden Cardiac Death: A Systematic Review.

Isaila O, Moroianu L, Hostiuc S Medicina (Kaunas). 2024; 60(3).

PMID: 38541144 PMC: 10972295. DOI: 10.3390/medicina60030418.

References

Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1953-66. DOI: 10.1056/NEJMoa030781. View

Kuiken T, Fouchier R, Schutten M, Rimmelzwaan G, van Amerongen G, van Riel D . Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003; 362(9380):263-70. PMC: 7112434. DOI: 10.1016/S0140-6736(03)13967-0. View

de Groot R, Baker S, Baric R, Brown C, Drosten C, Enjuanes L . Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013; 87(14):7790-2. PMC: 3700179. DOI: 10.1128/JVI.01244-13. View

Zaki A, van Boheemen S, Bestebroer T, Osterhaus A, Fouchier R . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814-20. DOI: 10.1056/NEJMoa1211721. View

Adhikari S, Meng S, Wu Y, Mao Y, Ye R, Wang Q . Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020; 9(1):29. PMC: 7079521. DOI: 10.1186/s40249-020-00646-x. View

Rauf A, Abu-Izneid T, Olatunde A, Khalil A, Alhumaydhi F, Tufail T . COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies. Int J Environ Res Public Health. 2020; 17(21). PMC: 7662254. DOI: 10.3390/ijerph17218155. View

Choo K, Cotton R, Jennings I, Fowler K, Danks D . Genetics of mammalian phenylalanine hydroxylase system. IV. Evidence of phenylalanine hydroxylase in a cultured human hepatoma cell line. Biochem Genet. 1980; 18(9-10):955-68. DOI: 10.1007/BF00500128. View

Lippi G, Plebani M . Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020; 58(7):1131-1134. DOI: 10.1515/cclm-2020-0198. View

Paliogiannis P, Zinellu A, Scano V, Mulas G, De Riu G, Pascale R . Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report. J Infect Dev Ctries. 2020; 14(7):685-690. DOI: 10.3855/jidc.12879. View

10.

Paliogiannis P, Mangoni A, Dettori P, Nasrallah G, Pintus G, Zinellu A . D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis. Front Public Health. 2020; 8:432. PMC: 7438945. DOI: 10.3389/fpubh.2020.00432. View

11.

Paliogiannis P, Zinellu A . Bilirubin levels in patients with mild and severe Covid-19: A pooled analysis. Liver Int. 2020; 40(7):1787-1788. PMC: 7264680. DOI: 10.1111/liv.14477. View

12.

Wang Y, Shi L, Wang Y, Duan G, Yang H . Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients. J Clin Lab Anal. 2020; 34(7):e23412. PMC: 7323086. DOI: 10.1002/jcla.23412. View

13.

Parohan M, Yaghoubi S, Seraji A . Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies. Hepatol Res. 2020; 50(8):924-935. PMC: 7273097. DOI: 10.1111/hepr.13510. View

14.

Plaut G, Aogaichi T . The separation of DPN-linked and TPN-linked isocitrate dehydrogenase activities of mammalian liver. Biochem Biophys Res Commun. 1967; 28(4):628-34. DOI: 10.1016/0006-291x(67)90360-9. View

15.

ENGELBERG H, Brudo I . Discriminative effect of rifampin of RNA replication of various RNA bacteriophages. J Virol. 1975; 16(2):340-7. PMC: 354673. DOI: 10.1128/JVI.16.2.340-347.1975. View

16.

Begg C, Mazumdar M . Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. View

17.

Sterne J, Egger M . Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001; 54(10):1046-55. DOI: 10.1016/s0895-4356(01)00377-8. View

18.

Duval S, Tweedie R . Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455-63. DOI: 10.1111/j.0006-341x.2000.00455.x. View

19.

Aloisio E, Chibireva M, Serafini L, Pasqualetti S, Falvella F, Dolci A . A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity. Arch Pathol Lab Med. 2020; 144(12):1457-1464. DOI: 10.5858/arpa.2020-0389-SA. View

20.

Bastug A, Bodur H, Erdogan S, Gokcinar D, Kazancioglu S, Kosovali B . Clinical and laboratory features of COVID-19: Predictors of severe prognosis. Int Immunopharmacol. 2020; 88:106950. PMC: 7480980. DOI: 10.1016/j.intimp.2020.106950. View